Materialise NV

Good day and welcome to the second quarter and half year 2026 Materialized NV Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question, you will need to press star 1-1 on your touchtone telephone. Please note this call may be recorded. I would like to turn the call over to Jody Burfening, Alliance Advisors and Best Relations. Please go ahead.

Thank you, Michelle, and thank you, everyone, for joining us today for Materialise's quarterly conference call. With us on the call are Brigitte de Vet-Veithen, Chief Executive Officer, and Koen Berges, Chief Financial Officer. Today's call and webcast are being accompanied by a slide presentation that reviews Materialise's strategic, financial, and operational performance for the second quarter and first half of 2026. To access the slides, if you have not already done so, please go to the investor relations section of the company's website at www.materialize.com. The earnings press release that was issued earlier today can also be found on that page. Before we get started, I'd like to remind you that management may make forward-looking statements regarding the company's plans, expectations, and growth prospects, among other things. These forward-looking statements are subject to known and unknown uncertainties and risks that could cause actual results to differ materially from the expectations expressed, including competitive dynamics and industry change. Any forward-looking statements, including those related to the company's future results and activities, represent management's estimates as of today and should not be relied upon as representing their estimates as of any subsequent day. Management disclaims any duty to update or revise any forward-looking statements to reflect future events or changes in expectations. A more detailed description of the risks and uncertainties and other factors that may impact the company's future business or financial results can be found in the company's most recent report on Form 20F filed with the SEC. Finally, management will discuss certain non-IFRS measures on today's conference call. A reconciliation table is contained in the earnings release and at the end of the slide presentation. With that, I would now like to turn the call over to Brigitte. Good morning, Brigitte. Good morning and good afternoon.

Thank you, everyone, for joining us today. You can find the agenda for our call on slide three. First, I will summarize the business highlights for the second quarter of 2026. Then I will pass the floor to Koen, who will take you through the second quarter and half-year financials. and finally I will come back and explain what we expect the remaining months of 2026 to bring. When we've completed our prepared remarks we'll be happy to respond to questions. Moving to slide four for the highlights of the second quarter 2026. I'd like to open by drawing your attention to our first half-year report now available on our investor relations website. This report reflects our compliance with the European reporting requirements. requirements that, as announced in our first quarter earnings call, led us to deliberately schedule this second quarter earnings release later in the quarter. I'm also pleased to announce some changes in our executive committee taking place as of early September. Those changes will further strengthen our leadership team and strategy execution. Annelies Misothen will join us as Chief Human Resource Officer to further strengthen our human resource agenda. Annelies brings more than 30 years of international HR leadership experience with a strong record in shaping people and organization strategies that support business growth, transformation, and employee engagement. Throughout her career, she has worked primarily in the life science sector as well as in telecom and fast-moving consumer goods in both Belgian and international environments. Most recently, Annelies served as CHRO at Galapagos, now a lakefront biotherapeutics, where she acted as a strategic advisor to the CEO and executive committee and led the HR function across all disciplines in an international setting. She played an important role in supporting the company through periods of growth, transformation, and organizational change, while also strengthening HR as a strategic partner to the business. She brings a wealth of experience, strong energy and a people-centered leadership style that will help us further our people agenda across the organization. Second, Filip Verlinde will join us in the newly created role as Chief Digital and Information Officer. This new role reflects the strategic importance of digital capabilities to simplify, scale and execute more effectively. Philip brings more than 35 years of experience in technology, digital, and transformation leadership. He spent 26 years at Philips, and most recently, he served as the Chief Digital and Information Officer at Barco, where he led IT and software across the global footprint. Throughout his career, he led large-scale technology, product, and digital transformation initiatives across engineering, consumer electronics, and healthcare technology, He brings deep experience in cloud and connected platform capabilities as well as AI to further drive our digital agenda across our units and markets. We are also making a leadership change in medical. Our medical unit is delivering strong results as evidenced by the strong growth this quarter. In addition, we see significant opportunities ahead. To fully capitalize on these opportunities, we have decided to look for a new leader for the medical segment, and Koen Peters will leave the company in September. The second quarter also marked the 30th anniversary of Materialise in the United States, a market that has been central to our growth strategy from the beginning. Over the years, we made several strategic acquisitions in the US, including OctoView, the market leader in orthopedic digital preoperative planning software, Link3D, an additive workflow and digital manufacturing software company, and Identify3D, a company that develops software to encrypt, distribute, and trace the flow of digital parts across complex supply chains. Today, we are one of the leading players globally, and our US office and team have been very instrumental in our global success. Looking now further at our business segment highlights at the second quarter on slide five. starting with medical. In the second quarter, we saw further evidence of the growing maturity of personalized theater and 3D printing during the eighth edition of our 3D planning and printing hospital forum in Høven, where we welcomed around 200 surgeons, radiologists, clinical engineers from hospitals across Europe and beyond to discuss the use of 3D printing in the hospital. What stood out in this year's discussion was the clear shift from what is the value of personalized 3D solutions to how can we scale this in clinical practice. The continued rise of in-house hospital 3D labs is evidence that 3D printing is becoming more established and operational. Now the discussions also confirm that Materialise is at the center of this trend. Not only as a software and service provider, but as a long-term partner helping hospitals integrate personalized care more broadly into daily practice. In the second quarter, we also announced an investment in Replasia, a Belgian medtech startup developing personalized 3D printed solutions and anatomical analysis software for hip preservation. Our goal is more personalized, less invasive orthopedic treatments that help patients maintain their natural anatomy and their quality of life for as long as possible. Our current hip portfolio is focused on replacement. Strategically, the investment in Replasia strengthens our position across the full spectrum of personalized hip care and complements our existing portfolio to hip preservation solutions. Preservation will play an important role as the market shifts towards less invasive approaches. A similar shift to less invasive approaches is happening in markets outside of orthopedics. One example in CMF, cranio-maxillofacial, is minimally invasive orthognathic surgery, or MIOT, a technique that allows surgeons to perform jaw surgery through smaller incisions. Smaller incisions mean that more patients will opt for surgery. At the same time, smaller incisions require a high level of precision during the surgery, and that is an area where materialize is well positioned with our software and device portfolio. The strong proof point of our position was the international MIOS meeting in Brazil in June, which brought together more than 200 maxillofacial experts from 13 countries, and where we trained surgeons in hands-on cadaver labs performed the surgeries in a safe and effective way. Turning now to software. In the second quarter, we officially released CoEM Pro to the market on May 15th, one month ahead of schedule. CoEM Pro is our cloud-based solution integrated with Magix that brings EM data management and build preparation together in one workflow, making it easier for teams to collaborate Standardize processes and automate recurring tasks. It centralizes AM data if it uses one source of the truth of the data across themes. We also formally released the GoEM Bricks offering, our automation platform that helps users reduce manual work, for example in the new product introduction process, and helps embed AM know-how more easily into their daily operations. Early customer onboarding since launch gives us encouraging initial validation of the offering. In addition, we have started the early adopter programs of CoEM NCI and CoEM Enterprise. Together, these steps mark the structural expansion of our metrics installed base into a connected platform that grows with customers over time. Turning to manufacturing now. Following the agreement we announced at the end of the first quarter, we completed the transfer of our RapidFed business to its management team on April 30th and the transfer of our iWare business on July 1st. With these closings, both businesses now continue independently under their existing leadership with greater focus and flexibility to pursue their next phase of growth. For materialized, These completed transactions are an important step in sharpening our portfolio and concentrating capital, resources, and leadership attention on the business lines with the strongest long-term scaling potential. In the case of eyewear, we retain a 20% minority stake, reflecting our continued confidence in the business. Looking at the second quarter results in manufacturing, aerospace remains a strong growth area of ours, with 40% revenue growth realized in the second quarter. This reflects our strong position in this space. A good example of our capabilities is a recent project with Lufthansa Technik. The project involved a small part in an aircraft cabin component that repeatedly failed in service and could not be sourced individually, meaning the entire assembly had to be replaced each time. By redesigning their part for additive manufacturing and producing it as a certified stand-alone component, Lufthansa Technik was able to turn a costly retiring replacement into a faster and significantly more cost-effective repair. Following this project, Materialise was named an official workbench for Lufthansa Technik Metal Parts, an important proof point of the trust we have built in certified aerospace production. Also, in the second quarter, we continued to build momentum in the defense market. Additive manufacturing can provide real value in defense by enabling spare parts and critical components to be produced closer to where they are needed, reducing dependence on vulnerable supply chains. With our combination of software and manufacturing capabilities, Materialise is well positioned to support that shift. In the second quarter, The Belgian Cyber Force and the Royal Higher Institute for Defence selected Materialise to lead a research consortium with Siris and InnoGom called Strike IT. The project focuses on secure and reliable digital manufacturing of spare parts, ensuring that digital files remain protected throughout the production process. Our identified 3D and QEM technologies will be instrumental in this project to build trust in additive manufacturing for mission-critical environments, like defects, and help make digital supply chains more resilient. Turning over to Koen now, who will present the financial results.